Combines strong US business development track record with in-depth mRNA expertiseGlobal remit with focus on growth of etherna’s portfolio of…
Combines strong US business development track record with in-depth mRNA expertiseGlobal remit with focus on growth of etherna’s portfolio of…
Name change to Abilita Therapeutics reflects the company’s focus and newly established capabilities to build an internal pipeline of first-…